Latest News
|
More Articles...
- Mysterious Heart Damage, Not Just Lung Troubles, Befalling COVID-19 Patients
- New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients
- MemorialCare Heart & Vascular Institute at Long Beach Medical Center—Only Southern California Site Participating in Atrial Fibrillation Clinical Trial—Enrolls First Successful Patient
- CardioFocus Announces U.S. FDA PMA Supplement Submission for the Breakthrough HeartLight X3 Endoscopic Ablation System
- VitalConnect Announces Launch of Arrhythmia Detection for Cardiac Patient Care
- Ablacon Announces Release of New and Improved Ablamap Technology Under Existing CE Mark
- Abbott Launches Next-generation Detection Technology in the U.S. and Europe, Offering a Smarter Approach to 24/7 Heart Monitoring for People with Irregular Heartbeats
- Ablacon Announces Release of New and Improved Ablamap Technology Under Existing CE Mark
- Adagio Medical Treats First Persistent Atrial Fibrillation Patient with One Shot+™ Cryoablation Catheter Utilizing Only Anatomical Markers For Accurate Imaging
- Biofourmis' RhythmAnalytics™ Platform Receives FDA Clearance for AI-Based Automated Interpretation of Cardiac Arrhythmias
|
|